Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin vs Ivermectin Combination Treatments for Bancroftian Filariasis
NCT04410406Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2020
- Primary completion
- Oct 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of moxidectin in lymphatic filariasis (LF), sponsored by Washington University School of Medicine. Started Aug 2020; status: completed.
02
Drugs
moxidectin
03
Conditions
lymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT04410406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410406.